Fluidigm Corporation (NASDAQ:FLDM) today announced total revenue for the fourth quarter of 2014 is expected to be approximately $33.4 million based on preliminary, unaudited financial data. Organic revenue for the fourth quarter of 2014 (excluding revenue attributable to the DVS Sciences acquisition, comprised of the CyTOF® 2 system and proteomics analytical consumables) is expected to be approximately $25.2 million.
Help employers find you! Check out all the jobs and post your resume.
